Stemcell Holdings Inc (STMM)
0.06
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Stemcell Holdings Enterprise Value
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
May 17, 2024 | -3.473M |
May 16, 2024 | -3.473M |
May 15, 2024 | -3.473M |
May 14, 2024 | -3.473M |
May 13, 2024 | -3.473M |
May 10, 2024 | -3.473M |
May 09, 2024 | -3.473M |
May 08, 2024 | -3.473M |
May 07, 2024 | -3.473M |
May 06, 2024 | -3.473M |
May 03, 2024 | -3.473M |
May 02, 2024 | -3.473M |
May 01, 2024 | -3.473M |
April 30, 2024 | -3.473M |
April 29, 2024 | -3.473M |
April 26, 2024 | -3.473M |
April 25, 2024 | -3.473M |
April 24, 2024 | -3.473M |
April 23, 2024 | -3.473M |
April 22, 2024 | -3.473M |
April 19, 2024 | -3.473M |
April 18, 2024 | -3.473M |
April 17, 2024 | -3.473M |
April 16, 2024 | -3.473M |
April 15, 2024 | -3.473M |
Date | Value |
---|---|
April 12, 2024 | -3.473M |
April 11, 2024 | -3.473M |
April 10, 2024 | -3.473M |
April 09, 2024 | -3.473M |
April 08, 2024 | -3.473M |
April 05, 2024 | -3.473M |
April 04, 2024 | -3.473M |
April 03, 2024 | -3.473M |
April 02, 2024 | -3.473M |
April 01, 2024 | -3.473M |
March 28, 2024 | -3.473M |
March 27, 2024 | -3.473M |
March 26, 2024 | -3.473M |
March 25, 2024 | -3.473M |
March 22, 2024 | -3.473M |
March 21, 2024 | -3.473M |
March 20, 2024 | -3.473M |
March 19, 2024 | -3.473M |
March 18, 2024 | -3.473M |
March 15, 2024 | -3.473M |
March 14, 2024 | -3.473M |
March 13, 2024 | -3.473M |
March 12, 2024 | -3.473M |
March 11, 2024 | -3.473M |
March 08, 2024 | -3.473M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-3.473M
Minimum
Jul 15 2020
-3.473M
Maximum
Jul 15 2020
-3.473M
Average
-3.473M
Median
Jul 15 2020
Enterprise Value Benchmarks
AIM ImmunoTech Inc | 7.729M |
Perspective Therapeutics Inc | 817.27M |
Protalix BioTherapeutics Inc | 55.51M |
Electromed Inc | 130.07M |
Armata Pharmaceuticals Inc | 187.82M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 1.037M |
Revenue (Quarterly) | 3.403M |
Total Expenses (Quarterly) | 1.582M |
EPS Diluted (Quarterly) | 0.04 |